Sionna Therapeutics, Inc. · NASDAQ:SION

Sionna Therapeutics, Inc. financial statements

Sionna Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022
Revenue0000
Cost of revenue647.0K668.0K
Gross profit-647.0K-668.0K
Research and development60.3M57.3M40.6M34.6M
Selling, general and administrative28.7M13.3M9.71M6.77M
Operating income-89.0M-70.6M-50.3M-41.4M
Depreciation and amortization647.0K668.0K583.0K122.0K
EBITDA-88.3M-69.9M-49.8M-41.3M
Income before tax-75.3M-61.7M-47.3M-40.2M
Income tax00
Net income-75.3M-61.7M-47.3M-40.2M
Earnings per share, basic-1.88-15.99-1.07-0.91
Earnings per share, diluted-1.88-15.99

Balance sheet

LineFY2025FY2024FY2023FY2022
Cash and equivalents58.5M37.8M38.5M54.8M
Short-term investments177.4M109.8M027.8M
Current assets241.4M151.0M39.2M83.8M
Property, plant and equipment2.23M2.47M
Total assets326.0M185.8M51.9M87.4M
Accounts payable769.0K1.19M719.0K557.0K
Current liabilities11.7M10.4M8.04M8.25M
Total debt8.68M9.75M10.5M
Total liabilities19.1M19.1M166.8M157.3M
Shareholders' equity306.8M-163.7M-114.9M-69.9M
Shares outstanding44.7M4.72M44.1M44.1M

Cash flow

LineFY2025FY2024FY2023FY2022
Cash from operations-66.3M-52.8M-43.7M-36.1M
Capital spending-377.0K-27.0K-1.12M-1.87M
Free cash flow-66.7M-52.8M-44.8M-37.9M
Cash from investing-118.7M-126.9M27.4M-29.3M
Cash from financing205.7M179.0M31.0K110.9M
Change in cash20.7M-733.0K-16.3M45.5M